At Organelle Therapeutics, Inc., we envisions becoming a global leader in biotechnology by leveraging its cutting-edge technologies to drive sustainable revenue growth through continuous licensing agreements (L/O). By advancing innovative therapies and consistently enhancing corporate value, we aim to build a foundation for long-term success and contribute to transforming healthcare on a global scale.